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Older adults have shown an attenuated postexercise increase in mus-
cle protein synthesis rates following ingestion of smaller amounts of
protein compared with younger adults. Consequently, it has been
suggested that older adults require the ingestion of more protein to
increase postexercise muscle protein synthesis rates compared with
younger adults. We investigated whether coingestion of 1.5 g of free
leucine with a single 15-g bolus of protein further augments the
postprandial muscle protein synthetic response during recovery from
resistance-type exercise in older men. Twenty-four healthy older men
(67  1 yr) were randomly assigned to ingest 15 g of milk protein
concentrate (MPC80) with (15GLEU; n  12) or without (15G; n 
12) 1.5 g of free leucine after performing a single bout of resistance-
type exercise. Postprandial protein digestion and amino acid absorp-
tion kinetics, whole body protein metabolism, and postprandial myo-
fibrillar protein synthesis rates were assessed using primed, continu-
ous infusions with L-[ring-2H5]phenylalanine, L-[ring-2H2]tyrosine,
and L-[1-13C]leucine combined with ingestion of intrinsically L-[1-
13C]phenylalanine-labeled milk protein. A total of 70  1% (10.5 
0.2 g) and 75  2% (11.2  0.3 g) of the protein-derived amino acids
were released in the circulation during the 6-h postexercise recovery
phase in 15GLEU and 15G, respectively (P  0.05). Postexercise
myofibrillar protein synthesis rates were 16% (0.058  0.003 vs.
0.049  0.002%/h, P  0.05; based on L-[ring-2H5]phenylalanine)
and 19% (0.071  0.003 vs. 0.060  0.003%/h, P  0.05; based on
L-[1-13C]leucine) greater in 15GLEU compared with 15G. Leucine
coingestion further augments the postexercise muscle protein syn-
thetic response to the ingestion of a single 15-g bolus of protein in
older men.
aging; dietary protein; exercise; leucine; muscle protein synthesis;
sarcopenia
INTRODUCTION
The age-related decline in skeletal muscle mass and strength,
termed sarcopenia, is accompanied by impairments in func-
tional capacity and an increased risk of developing chronic
metabolic diseases (4). Whereas basal muscle protein synthesis
and breakdown rates appear to be unaffected by age (33), the
muscle protein synthetic response to the main anabolic stimuli,
namely food intake and physical activity, seems to be blunted
in older individuals (47). This anabolic resistance is now consid-
ered a central factor contributing to the progression of sarcopenia.
A single session of resistance-type exercise strongly in-
creases muscle protein synthesis rates (36) and therefore rep-
resents an effective strategy to compensate for anabolic resis-
tance. For older individuals, ingestion of more than 20 g of
protein is required to augment postexercise muscle protein
synthesis rates (10, 36, 53). Older individuals possess the
capacity to further increase the postexercise muscle protein
synthetic response by ingesting larger protein doses, with the
ingestion of 40 g of protein further enhancing the muscle
protein synthetic response (53, 54). However, older individuals
seldom consume 40 g of protein in a single meal (40, 41).
Therefore, research is warranted to determine nutritional strat-
egies that can augment the muscle protein synthetic response to
ingestion of small(er) amounts of protein during recovery from
resistance-type exercise in older adults.
Leucine has been established as one of the amino acids with
greater anabolic properties due to its ability to stimulate mam-
malian target of rapamycin complex 1 (mTORC1) activity to
phosphorylate key anabolic signaling proteins (i.e., S6K1) in
skeletal muscle tissue (3, 17). Previous work has demonstrated
that coingestion of free leucine augments the muscle protein
synthetic response to protein or amino acid ingestion in older
individuals at rest (7, 9, 12, 13, 48) and after a single bout of
resistance-type exercise (2, 7, 9, 12, 13). It has also been
demonstrated that leucine coingested with main meals aug-
ments the integrated muscle protein synthetic response to
resistance-type exercise assessed over multiple days (30).
However, as leucine also stimulates splanchnic tissue protein
synthesis rates (29, 39), it could be speculated that free leucine
coingestion stimulates the uptake and incorporation of dietary
protein-derived amino acids in the splanchnic tissues, thereby
attenuating the postprandial release of dietary protein-derived
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amino acids in the circulation. It remains to be established
whether this would preclude the impact of free leucine coinges-
tion to further increase postexercise muscle protein synthesis
rates. In short, it remains unclear whether or not free leucine
coingestion impacts postprandial protein handling following
the ingestion of a small amount of protein during postexercise
recovery in older individuals. Therefore, in the present study,
we assessed postprandial protein handling and the muscle
protein synthetic response following ingestion of a single 15-g
bolus of protein with or without additional free leucine (1.5 g)
during recovery from a single bout of resistance-type exercise
in older individuals.
We hypothesized that coingestion of 1.5 g of free leucine
with a single bolus of 15 g of protein attenuates the postpran-
dial release of protein-derived amino acids in the circulation
compared with the ingestion of 15 g of protein. Furthermore,
we hypothesized that, despite a potential attenuated rise in
postprandial plasma amino acid availability, free leucine co-
ingestion will further increase postexercise muscle protein
synthesis rates and allow for a greater incorporation of the
available dietary protein-derived amino acids into myofibrillar
protein. To test our hypothesis, we selected 24 healthy older
(67  1 yr) men who ingested 15 g of protein with or without
1.5 g of free leucine during recovery from a single bout of
resistance-type exercise. By combining the ingestion of spe-
cifically produced intrinsically L-[1-13C]phenylalanine- and
L-[1-13C]leucine-labeled milk protein concentrate with the ad-
ministration of primed continuous infusions of L-[ring-2H5]
phenylalanine, L-[1-13C]leucine, and L-[ring-2H2]tyrosine, we
were able to assess protein digestion and amino acid absorption
kinetics, the increase in muscle protein synthesis rate, and the
postprandial incorporation of dietary protein-derived amino
acids during recovery from exercise in older individuals.
MATERIALS AND METHODS
Subjects. A total of 24 healthy, normoglycemic, older men (67  1
yr) were selected to participate in the present study. Subjects’ char-
acteristics are presented in Table 1. Subjects were randomly assigned
to ingest either 15 g of protein (15G: n  12) or 15 g of protein with
1.5 g of crystalline free leucine (15GLEU: n  12) in a double-blind
fashion after completing a single bout of whole body resistance-type
exercise. Randomization was performed by an independent researcher,
who created a table in Excel (Microsoft) using the random number
generator function, which was coupled to the different beverages before
sorting the number column in order of low to high. The independent
researcher also prepared and masked the test beverages on the test
day. All subjects were informed of the nature and possible risks of the
experimental procedures before giving written informed consent was
obtained. The study was approved by the Medical Ethics Committee
of the Maastricht University Medical Centre, The Netherlands (METC
14-3-052) and conformed to standards for the use of human subjects
in research as outlined in the most recent version of the Helsinki
Declaration. All participants provided written informed consent be-
fore participation. This study is part of a greater project, which was
registered at The Netherlands Trial Registry as NTR4492. Data from
the 15G group was published previously as part of a protein dose-
response study conducted in parallel within the same project (22).
Pretesting. Participants arrived at the laboratory at 0830 by car or
public transportation in an overnight-fasted state. Upon arrival, body
weight, body composition, and bone mineral content were measured
with dual-energy X-ray absorptiometry (DEXA, Discovery A; Ho-
logic, Bedford, MA). Thereafter, all participants performed an oral
glucose tolerance test (OGTT). Plasma glucose and insulin concen-
trations were measured to determine oral glucose intolerance and/or
the presence of type 2 diabetes according to 2006 American Diabetes
Association guidelines (1). All subjects were screened on medical
issues and excluded if any gastrointestinal, neurological, or renal
diseases were present.
Subjects were cleared to perform resistance-type exercise by a
cardiologist, who examined electrocardiograms (ECG) measured at
rest and during submaximal cycling (performed at 70% of age-
predicted heart rate maximum). The subjects were then familiarized
with the exercise equipment and physical activity protocol. Subjects
first performed a 10-min cycling warm-up at 70% of their age-
predicted heart rate maximum before completing an estimation of
their one-repetition maximum (1RM) on leg press and leg extension
exercises by using the multiple repetitions testing procedure (28). For
each exercise, subjects performed 10 submaximal repetitions to warm
up and become familiarized with the equipment and to have lifting
technique critiqued and corrected. Subjects then performed sets at
progressively increasing loads until failing to complete a valid repe-
tition, judged by their inability to complete the full range of motion for
an exercise. Ideally, subjects failed within 3–6 repetitions during the
last and heaviest set. A 2-min resting period between subsequent
attempts was allowed. The pretesting and experimental trials were
separated by a period of at least 7 days.
Diet and physical activity. All volunteers were instructed to refrain
from any exhaustive physical activity and to keep their diet as consistent
as possible 72 h before the trial. Subjects filled in dietary records for
48 h immediately before the experimental trial. Subjects consumed
8.6  0.5 MJ/day on average, with 47  1 energy% (En%) as
carbohydrate, 33  1 En% as fat, and 18  1 En% as protein. Dietary
protein intake averaged 1.1  0.1 g/kg body wt. On the evening
before the experiment, all subjects consumed a standardized meal
(22.0  0.6 kJ/kg body wt consisting of 55 En% as carbohydrate, 20
En% as protein, and 25 En% as fat).
Experimental protocol. At 0800, participants reported to the labo-
ratory in a fasted and rested state and had Teflon catheters inserted
into the antecubital veins of one arm and the top of the opposite hand.
At 0830 (t  150 min), and a background blood sample was taken
before the initiation of the tracer infusion protocol. The plasma and
intracellular phenylalanine and leucine pools were primed with a
single intravenous dose (priming dose) of L-[ring-2H5]phenylalanine
Table 1. Subjects’ characteristics
15G 15GLEU P
Age, yr 69  2 66  2 0.45
Total body mass, kg 78.8  3.2 79.0  2.4 0.96
Total lean mass, kg 57.6  2.3 58.1  1.5 0.86
Appendicular lean mass, kg 24.9  1.1 25.6  0.7 0.64
Percent body fat, % 23.9  0.9 23.2  1.2 0.62
Height, m 1.75  0.02 1.78  0.01 0.23
BMI, kg/m2 25.8  0.8 24.9  0.8 0.43
HbA1c, % 5.3  0.1 5.3  0.1 0.80
Resting glucose, mmol/l 5.8  0.2 6.2  0.2 0.13
Resting insulin, mU/l 9.3  0.9 8.4  1.2 0.59
HOMA-IR 2.4  0.2 2.4  0.4 1.00
MVPA, min 145  31 160  33 0.95
1RM - leg press, kg 179  8 166  6 0.23
1RM - leg extension, kg 86  6 88  2 0.79
1RM - lat pulldown, kg 60  4 62  4 0.78
1RM - chest press, kg 60  6 58  5 0.77
Values are means  SE; n  12 per treatment group. 15G, 15 g of dietary
protein; 15GLEU, 15 g dietary protein 1.5 g of free crystalline leucine;
HOMA-IR, homeostasis model assessment of insulin resistance; 1RM, one
repetition maximum; HbA1c, glycosylated hemoglobin; MVPA, moderate-to-
vigorous physical activity; Resting, resting and fasted values. Data were
analyzed with Student’s unpaired t-test. No differences were detected between
groups.
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(3.6 mol/kg), L-[ring-2H2]tyrosine (1.10 mol/kg), and L-[1-13C]
leucine (7.19 mol/kg). Once primed, the continuous stable isotope
infusion was initiated (infusion rates: 0.06 mol·kg1·min1 L-[ring-
2H5]phenylalanine, 0.018 mol·kg1·min1 L-[ring-2H2]tyrosine, and
0.12 mol·kg1·min1 L-[1-13C]leucine; Cambridge Isotope Labora-
tories, Andover, MA). Participants rested for 1.5 h until 1000
(t  60 min), when the participants completed the resistance-type
exercise session. At 1100 (t  0 min), immediately after the resis-
tance-type exercise session, subjects had a blood sample and muscle
biopsy collected from a randomized leg. Subsequently, subjects in-
gested a 500-ml beverage containing 15 g of intrinsically L-[1-13C]phe-
nylalanine- and L-[1-13C]leucine-labeled milk protein (MPC80) alone
(15G) or with an added 1.5 g of crystalline free leucine (15GLEU)
(Table 2). The beverages contained 1.5 ml of vanilla extract to
improve palatability (Dr. Oetker, Amersfoort, The Netherlands).
Blood samples (10 ml) were subsequently taken at t  30, 60, 90, 120,
180, 240, 300, and 360 min after protein ingestion. A second muscle
biopsy was obtained from the contralateral leg at 1700 (t  360 min),
signifying the end of the experimental trial.
Blood samples were collected in EDTA-containing tubes and
centrifuged at 1,000 g for 10 min at 4°C. Aliquots of plasma were
frozen in liquid nitrogen and stored at –80°C. Muscle biopsies were
obtained from the middle region of the vastus lateralis muscle 15 cm
above the patella and ~4 cm below entry through the fascia, using the
percutaneous needle biopsy technique (5). Muscle samples were
dissected carefully and freed from any visible nonmuscle material.
The muscle samples were immediately frozen in liquid nitrogen and
stored at –80°C until further analysis.
Resistance-type exercise protocol. The exercise protocol consisted
of 60 min of moderate-to-high intensity whole-body resistance-type
exercise. After 10 min of self-paced cycling at 100 W with a cadence
of 60–80 RPM, subjects performed 5 sets of 10 repetitions on the
horizontal leg press machine (Technogym BV, Rotterdam, Nether-
lands), 2 sets of 10 repetitions on the lat pull down machine (Tech-
nogym BV), 2 sets of 10 repetitions on the chest press machine and 5
sets of 10 repetitions on the leg extension machine (Technogym). The
first set of the lower body exercises were performed at 50% 1RM and
sets 2–5 were performed at 75–80% 1RM. All sets on the upper body
exercises were performed at 75–80% 1RM. Subjects were allowed to
rest for 2 min between all sets.
Preparation of tracer and production of intrinsically labeled protein.
The stable isotope tracers L-[ring-2H5]phenylalanine, L-[1-13C]leu-
cine, and L-[ring-2H2]tyrosine were purchased from Cambridge Iso-
topes and dissolved in 0.9% saline before infusion (Basic Pharma,
Geleen, The Netherlands). Continuous intravenous infusions were
performed using a calibrated IVAC 598 pump (San Diego, CA).
Intrinsically L-[1-13C]phenylalanine- and L-[1-13C]leucine-labeled
milk protein (MPC80) was extracted from whole milk obtained during
the constant infusion of L-[1-13C]phenylalanine (455 mol/min) and
L-[1-13C]leucine (200 mol/min) for 96 h in a lactating dairy cow (8,
44). The milk was collected, processed, and fractionated into the
MPC80 similarly to what has been previously described (19, 37, 44).
The L-[1-13C]phenylalanine and L-[1-13C]leucine enrichments in
MPC80 were measured by gas chromatography-combustion-isotope
ratio mass spectrometry (GC-C-IRMS, MAT 252; Finnigan, Breman,
Germany) and averaged 38.3 mole percent excess (MPE) and 10.8
MPE, respectively. The proteins met all chemical and bacteriological
specifications for human consumption.
Plasma and muscle analysis. Plasma glucose and insulin concen-
trations were analyzed using commercially available kits (GLUC3,
Roche, Ref. 05168791 190; and Immunologic, Roche, Ref. 12017547
122, respectively). Plasma amino acid concentrations and enrichments
were determined by gas chromatography-mass spectrometry analysis
(GC-MS; Agilent 7890A GC/5975C; MSD, Wilmington, DE).
Myofibrillar protein-bound L-[ring-2H5]phenylalanine enrichments
were determined by GC-MS analysis, whereas the L-[1-13C]phe-
nylalanine and L-[1-13C]leucine enrichments were determined by




Aspartic acid 0.92 0.92













Values are expressed in g. 15G, 15 g of dietary protein; 15GLEU, 15 g of
dietary protein  1.5 g of free crystalline leucine.
Fig. 1. Plasma glucose (A, mmol/l) and insulin concentrations (B, mU/l)
following ingestion of 15 g of milk protein (15G; n  12) or 15 g of milk
protein coingested with 1.5 g of free leucine (15GLEU; n  12) after
resistance-type exercise in older men. Dotted line represents ingestion of the
beverage. Values represent means  SE. Data were analyzed with repeated-
measures (time  treatment group) ANOVA. A: time effect, P  0.01;
treatment effect, P 	 0.05; time  treatment group, P 	 0.05. B: time effect,
P  0.01; treatment effect, P 	 0.05; time  treatment group, P 	 0.05.
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GC-C-IRMS (Trace GC Ultra, IRMS model MAT 253; Thermo
Scientific) (20).
Western blotting. Muscle was homogenized as previously described
(46), 10 l of protein was loaded, and standard SDS-PAGE proce-
dures were followed. Antibodies included total and phosphorylated
mTOR (cat. nos. Total: 2972, Ser2448: 2971), S6K1 (cat nos. Total:
9202, Thr389: 9205), RS6 (cat nos. Total: 2217, Ser235/236: 4856),
eukaryotic initiation factor 4E-binding protein-1 (4E-BP1; cat. nos.
Total: 9452, Thr37/46: 9459). 
-tubulin (cat no. 2125) was used as
a loading control. All antibodies were purchased from Cell Sig-
naling Technology (Danvers, MA). All samples for a given protein
were detected on the same membrane using chemiluminescence
and the FluorChem HD imaging system (Alpha Innotech, Santa
Clara, CA).
Calculations. Ingestion of L-[1-13C]phenylalanine-labeled protein,
intravenous infusion of L-[ring-2H5]phenylalanine, and blood sam-
ple enrichment values were used to assess whole body amino acid
kinetics in non-steady-state conditions. Total, exogenous, and
endogenous phenylalanine rates of appearance and plasma avail-
ability of dietary protein-derived phenylalanine that appeared in
the systemic circulation as a fraction of total amount of phenylal-
anine that was ingested, (Pheplasma) were calculated using modified
Steele’s equations (6, 11, 52). Myofibrillar protein fractional syn-
thetic rate (FSR) was calculated using the standard precursor-
product method (Eq. 1).
FSR% · h1  Em2  Em1Eprecursorxt  100 (1)
Em2 – Em1 represents the change in muscle protein bound L-[1-
13C]leucine or L-[ring-2H5]phenylalanine enrichment. Eprecursor rep-
resents the average plasma L-[1-13C]leucine or L-[ring-2H5]phe-
nylalanine enrichment during the tracer incorporation period; t indi-
cates the time interval (h) between biopsies.
Statistics. Data are expressed as means  SE or as box-whisker
plots. Baseline characteristics between groups were compared using
Student’s unpaired t-test. A two-factor repeated-measures ANOVA
(time  treatment) with time as within-subjects factor and treatment
group as between-subjects factor was performed for the analysis of
plasma amino acid concentrations, plasma tracer enrichments, whole
body kinetics, and glucose and insulin concentrations. The analysis
was carried out for the period starting at the time of protein admin-
istration, between t  0 and 360 min. Upon identification of a significant
time  treatment interaction, Tukey’s post hoc testing was used to
identify time points in which the treatments differed. Non-time-depen-
dent variables (i.e., whole body metabolism, FSR values, L-[1-13C]phe-
nylalanine myofibrillar enrichments) were compared between treatment
groups using Student’s unpaired t-tests. Statistical significance was set at
P  0.05. All calculations were performed using SPSS 21.0 (IBM,
Chicago, Il).
Fig. 2. Plasma leucine (A), phenylalanine (C), and tyrosine (D) concentrations (mol/l) following ingestion of 15 g of milk protein (15G; n  12) or 15
g of milk protein coingested with 1.5 g of free leucine (15GLEU; n  12) during recovery from resistance-type exercise in older men. Dotted line
represents ingestion of the beverage. Values for A, C, and D represent means  SE. Data were analyzed with repeated-measures (time  treatment group)
ANOVA. A: time effect, P  0.01; treatment effect, P  0.01; time  treatment group, P  0.01. C: time effect, P  0.01; treatment effect, P  0.01;
time  treatment group. P 	 0.05. D: time effect, P  0.01; treatment effect, P  0.01; time  treatment group, P 	 0.05. Plasma leucine area under
the curves over 360 min (B, mol·360 min·l1) are presented as box and whisker plots. Boxes represent 25th to 75th percentiles. Horizontal lines and
crosses within boxes represent medians and means, respectively. Whiskers represent minimum and maximum values. Data were analyzed with Student’s
unpaired t-test. *Significant difference (P  0.05) from 15G.
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RESULTS
Plasma concentrations. Plasma glucose (Fig. 1A) and insulin
(Fig. 1B) concentrations after protein ingestion did not differ
between the 15G and 15GLEU groups (P 	 0.05). Plasma
insulin concentrations increased after protein ingestion in both
treatments, reaching peak levels 30 min after protein ingestion.
Plasma leucine concentrations (Fig. 2A) increased rapidly
following protein ingestion (P  0.01) but were greater in
15GLEU (peak values 407  23 mol/l) compared with 15G
(peak values 234  16 mol/l, P  0.01). Area under the
curve (AUC; Fig. 2B) analysis revealed that plasma leucine
availability over the 6-h postprandial was ~1.8-fold greater in
the 15GLEU group compared with the 15G group (P 
0.001). Plasma phenylalanine concentrations (Fig. 2C) in-
creased rapidly following protein ingestion (time effect, P 
0.01) along with a main effect for treatment (treatment effect,
P  0.01), but no time  treatment interaction (P 	 0.05).
Plasma tyrosine concentrations (Fig. 2D) increased following
protein ingestion (time effect, P  0.01) along with a main
effect for treatment (treatment effect, P  0.01) but no time 
treatment interaction (P 	 0.05).
Plasma amino acid enrichments. Plasma enrichments from
ingested (L-[1-13C]phenylalanine), infused (L-[ring-2H5]phe-
nylalanine), and ingested and infused (L-[1-13C]leucine) amino
acid tracers did not differ between treatments before protein
ingestion (t  0 min, P 	 0.05). After protein ingestion,
plasma L-[1-13C]phenylalanine enrichments, originating from
the ingested protein, increased in both groups, reaching peak
values at t  60 min in 15G (9.6  0.5 MPE) and t  120 min
in 15GLEU (8.7  0.5 MPE) in 15GLEU. Plasma L-[ring-
2H5]phenylalanine enrichments decreased after protein inges-
tion in both groups (P  0.001), but no significant group effect
was detected (P 	 0.05). Plasma L-[1-13C]leucine enrichments
increased after protein ingestion (P  0.001), but no significant
group effects were detected (P 	 0.05).
Whole body amino acid kinetics. Exogenous phenylalanine
appearance rates (Fig. 3A) increased following protein inges-
tion, with peak levels being reached at t  60 min in both
treatment groups (15G, 0.19  0.01; 15GLEU, 0.16  0.02
mol Phe·kg1·min1, P 	 0.05). Dietary protein-derived
amino acid availability, calculated as a fraction of the total
amount of ingested protein (Fig. 3B), was higher in 15G
(75  2%) than in 15GLEU (70  1%, P  0.05).
Whole body protein synthesis rates did not differ between
the treatment groups (15G, 0.60  0.01; 15GLEU, 0.59 
0.01 mol Phe·kg1·min1, P 	 0.05). Whole body protein
breakdown rates did not differ between the treatment groups
(15G, 0.49  0.01; 15GLEU, 0.49  0.01 mol Phe·
kg1·min1, P 	 0.05). Protein ingestion resulted in a positive
whole body protein net balance, with no differences ob-
served between the treatment groups (15G, 0.108  0.004;
15GLEU, 0.105  0.003 mol Phe·kg1·min1, P 	 0.05).
Furthermore, leucine coingestion did not appear to influence
whole body phenylalanine oxidation rates (15G, 0.049 
0.003; 15GLEU, 0.046  0.002 mol Phe·kg1·min1, P 	
0.05).
Myofibrillar FSRs and protein-bound enrichments. Myofi-
brillar L-[1-13C]leucine and L-[ring-2H5]phenylalanine enrich-
ments were measured in muscle samples collected immediately
before protein ingestion and after the 6-h postprandial period.
The postprandial increase in myofibrillar protein-bound L-[1-
13C]leucine enrichments tended to be greater in 15GLEU
than in 15G (0.0360  0.0016 vs. 0.0314  0.0016 MPE,
respectively, P  0.055). The postprandial increase in myofi-
brillar protein-bound L-[ring-2H5]phenylalanine enrichment
was greater in 15GLEU than in 15G (0.0330  0.0015 vs.
0.0278  0.0011 MPE, respectively, P  0.05).
Myofibrillar protein FSRs (in %/h) were calculated using
L-[ring-2H5]phenylalanine plasma (Fig. 4A) and muscle pro-
tein-bound enrichments and using L-[1-13C]leucine (Fig. 4B)
plasma and muscle protein-bound enrichments. When based
on L-[ring-2H5]phenylalanine, myofibrillar protein FSR was
~16% greater in 15GLEU (0.0575  0.0032%/h) than in
15G (0.0495  0.0021%/h, P  0.05). When based on L-[1-
13C]leucine, myofibrillar protein FSR was ~19% greater in
15GLEU (0.0710  0.0048%/h) than in 15G (0.0598 
0.0030%/h, P  0.05). L-[1-13C]phenylalanine myofibrillar
protein-bound enrichments (Fig. 5) were not different in
Fig. 3. Exogenous phenylalanine rate of appearance (Ra) (A, mol Phe·kg1·min1) following ingestion of 15 g of milk protein (15G; n  12) or 15 g
of milk protein coingested with 1.5 g of free leucine (15GLEU; n  12) during recovery from resistance-type exercise in older men. Dotted line
represents ingestion of the beverage. Values for A represent means  SE. Data were analyzed with repeated-measures (time  treatment group) ANOVA.
A: time effect, P  0.01; treatment effect, P  0.05; time  treatment group, P 	 0.05. Dietary protein-derived amino acid plasma availability (B),
calculated as a fraction of the total amount of ingested protein (%ingested protein), are presented as box and whisker plots. Boxes represent 25th to 75th
percentiles. Horizontal lines and crosses within boxes represent medians and means, respectively. Whiskers represent minimum and maximum values.
Data were analyzed with Student’s unpaired t-test. *Significantly different (P  0.05) from 15G.
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15GLEU (0.0205  0.0022 MPE) compared with 15G
(0.0171  0.0017 MPE, P  0.24).
Cellular signaling analyses. The phosphorylation status (ra-
tio of phosphorylated to total protein) of key proteins involved
in the initiation of muscle protein synthesis are presented in
Fig. 6. Phosphorylation of S6K1 (Fig. 6B) decreased in both
groups over time (time effect, P  0.01). Phosphorylation of
4E-BP1 (Fig. 6D) increased over time and to a greater extent in
15G compared with 15GLEU (P  0.01).
DISCUSSION
In the present study, we examined the impact of free leucine
coingestion on postprandial protein handling and the subse-
quent muscle protein synthetic response following the inges-
tion of 15 g of protein during recovery from resistance-type
exercise in older men. We observed that 70–75% of the
dietary-derived amino acids was absorbed into the circulation
6 h after the ingestion of 15 g of protein. Coingesting 1.5 g of
free leucine with 15 g of protein further increased postexercise
myofibrillar protein synthesis rates but did not significantly
increase the incorporation of dietary protein-derived amino
acids in myofibrillar protein.
We administered a primed, continuous intravenous infusion
of L-[ring-2H5]phenylalanine, L-[ring-2H2]tyrosine and L-[1-
13C]leucine throughout a 6-h postexercise recovery period in
older individuals. Following exercise, participants ingested 15
g of intrinsically L-[1-13C]phenylalanine-labeled milk protein
with or without 1.5 g of free leucine. With this experimental
protocol, we were able to assess in vivo protein digestion and
amino acid absorption kinetics, whole body protein metabo-
lism, myofibrillar protein synthesis, and the incorporation of
dietary protein-derived amino acids in muscle protein (8).
After protein ingestion, we observed a rapid rise in circulating
plasma amino acid concentrations (Fig. 2) and an increase in
the rate of exogenous phenylalanine appearance (Fig. 3A),
demonstrating rapid protein digestion and subsequent absorp-
tion of dietary protein-derived amino acids during recovery
from exercise. As expected, fortification with 1.5 g of free
leucine resulted in greater peak plasma leucine concentrations
(407  23 vs. 234  16 mol/l, P  0.01) at t  30 min and
1.8-fold greater plasma leucine availability over the entire 6-h
postprandial period compared with the ingestion of 15 g of
protein (P  0.01). We observed 70–75% of dietary protein-
derived amino acid absorption into the circulation over the 6-h
postprandial period in both groups. This seems to have been
much more compared with recent work from our laboratory
using the same methodology (21, 34, 35). The apparent dis-
crepancy is attributed to the relatively small amount of dietary
protein that was provided in the present study along with the
extended 6-h postprandial assessment period, implying that
more protein-derived amino acids will be absorbed during such
an extended postprandial period with a relatively smaller bolus
of protein being ingested (22). Free leucine fortification
seemed to compromise protein digestion and/or amino acid
absorption, as dietary protein-derived phenylalanine availabil-
ity was lower following leucine coingestion when assessed
over the entire 6-h postprandial period (10.5  0.2 vs. 11.2 
0.3 g, P  0.05). This was attributed to a mild attenuation of
exogenous amino acid appearance rates observed between
t  30 and 120 min (Fig. 3A). It could be speculated that the
added free leucine might have stimulated splanchnic amino
acid retention of dietary-protein derived amino acids during
first pass. In agreement, prior work in neonatal pigs has
demonstrated that free leucine coingested with a low protein
dose stimulates an increase in jejunum, but not liver, protein
synthesis (29, 39). All together, our data demonstrate that free
Fig. 5. L-[1-13C]phenylalanine incorporation into myofibrillar protein (MPE)
following ingestion of 15 g of milk protein (15G; n  12) or 15 g of milk
protein coingested with 1.5 g of free leucine (15GLEU; n  12) during
recovery from resistance-type exercise in older men. Boxes represent 25th to
75th percentiles. Horizontal lines and crosses within boxes represent medians
and means, respectively. Whiskers represent minimum and maximum values.
Data were analyzed with Student’s unpaired t-test. No significant difference
between groups (P  0.24).
Fig. 4. Myofibrillar protein fractional syn-
thetic rates (FSR, in %/h) assessed using
L-[ring-2H5]phenylalanine (A) and L-[1-13C]
leucine (B) and following ingestion of 15 g
of milk protein (15G; n  12) or 15 g of milk
protein coingested with 1.5 g of free leucine
(15GLEU; n  12) after resistance-type
exercise in older men. Boxes represent
25th to 75th percentiles. Horizontal lines and
crosses within boxes represent medians and
means, respectively. Whiskers represent mini-
mum and maximum values. Data were ana-
lyzed with Student’s unpaired t-test. *Signif-
icantly different (P  0.05) from 15G.
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leucine coingestion further increases the postprandial rise in
leucine concentrations but attenuates the rate of appearance of
dietary protein-derived amino acids into the circulation.
By administering a primed, continuous intravenous infusion
of L-[ring-2H5]phenylalanine and L-[ring-2H2]tyrosine and pro-
viding intrinsically L-[1-13C]phenylalanine-labeled protein, we
were able to assess postprandial whole body protein synthesis,
breakdown, net balance, and oxidation. In both groups, protein
ingestion resulted in a positive whole body net protein balance
during postexercise recovery. However, fortification with free
leucine did not further impact whole body postprandial protein
synthesis, breakdown, or net balance. These findings are in
agreement with prior work in older men at rest (38) and in
younger men during postexercise recovery (25). Despite pre-
vious reports that leucine administration lowers whole body
amino acid oxidation rates (24, 32), we did not observe this
effect. These studies achieved far greater plasma leucine avail-
ability compared with the present study, which may lead to a
reduction in protein breakdown rates (32, 42), thereby lowering
the availability of amino acids for oxidation (25, 42). Our
present data align with recent work administering similar,
meal-like amounts of leucine (~4.5 g total) (38), and demon-
strate that leucine coingestion does not impact whole body
phenylalanine oxidation rates.
Changes in whole body protein metabolism do not neces-
sarily reflect changes on a muscle tissue level. Therefore, we
also collected skeletal muscle biopsies to directly assess the
impact of leucine fortification of a low-protein dose on intra-
muscular signaling and the muscle protein synthetic response
to feeding. Resistance-type exercise and protein ingestion ac-
tivate intramuscular signaling proteins that regulate protein
translation, with mTOR and its downstream targets S6K1,
RS6, and 4E-BP1 being of particular relevance. We observed
no differences in mTOR or RS6 phosphorylation, but we
detected a decrease in S6K1 phosphorylation over time. These
findings align with previous work showing a rapid increase in
S6K1 activity following exercise, which subsides over 3–6 h
(26, 51). Considering that biopsy timing was intended to assess
the muscle protein synthetic response during the entire post-
prandial period, it is most likely that transient increases in
signaling activity had subsided by 6 h. However, 4E-BP1
phosphorylation increased over time in both groups, and to a
greater extent after the ingestion of 15 g of protein compared
with the ingestion of 15 g with leucine. We speculate that the
Fig. 6. Muscle phosphorylation (Phos) status [ratio of phosphorylated to total protein, arbitrary unit (AU)] of mammalian target of rapamycin (mTOR; A) S6
protein kinase-1 (S6K1; B), ribosomal protein S6 (RS6; C), and eukaryotic translation initiation factor 4E-binding protein-1 (4E-BP1; D) in older men during
recovery from resistance-type exercise (0 min) and 360 min after ingestion of 15 g of milk protein (15G; n  12) or 15 g of milk protein coingested with 1.5
g of free leucine (15GLEU; n  12). Boxes represent 25th to 75th percentiles. Horizontal lines and crosses within boxes represent medians and means,
respectively. Whiskers represent minimum and maximum values. Data were analyzed with repeated-measures (time  treatment group) ANOVA. A: time effect,
P 	 0.05; treatment effect, P 	 0.05; time  treatment group, P 	 0.05. B: time effect, P  0.01; treatment effect, P 	 0.05; time  treatment group, P 	
0.05. C: time effect, P 	 0.05; treatment effect, P 	 0.05; time  treatment group, P 	 0.05. D: time effect, P  0.01; treatment effect, P 	 0.01; time 
treatment group, P  0.01 *Significantly different (P  0.05) compared with t  0 min; †significantly different (P  0.05) from 15GLEU at the same time
point.
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higher leucine availability in 15GLEU may have transiently
activated 4E-BP1 at an earlier time compared with 15G (14,
18, 23), which steadily activated 4E-BP1 over the 6-h post-
prandial period (26, 49).
Combining stable-isotope-labeled amino acid infusions with
ingestion of intrinsically labeled protein, we were able to
assess muscle protein synthesis rates under both steady-state
(L-[1-13C]leucine) as well as non-steady-state (L-[ring-2H5]
phenylalanine) precursor conditions (8). Previous work has
demonstrated that the ingestion of a low-protein dose (20 g)
following resistance-type exercise does not further stimulate an
increase in muscle protein synthesis rates in older individuals
(53, 54). In the present study, free leucine coingested with a
low-protein dose (15 g) increased myofibrillar protein synthe-
sis rates by 16% (L-[ring-2H5]phenylalanine, Fig. 4A) and 19%
(L-[1-13C]leucine, Fig. 4B) compared with the ingestion of 15
g of protein. These findings are in line with multiple studies
demonstrating that free leucine coingestion can further in-
crease the muscle protein synthetic response to protein inges-
tion in older individuals at rest (2, 9, 12, 13, 30, 48) and
during recovery from resistance-type exercise (2, 7, 9, 12, 13,
30). In the present study, participants ingested intrinsically
L-[1-13C]phenylalanine-labeled protein, allowing us to di-
rectly assess the metabolic fate of the dietary protein-derived
amino acids (21, 44, 48). Despite the greater postprandial
muscle protein synthetic response following the coingestion of
free leucine, we did not observe a significantly greater L-[1-
13C]phenylalanine enrichment in myofibrillar protein in
15GLEU compared with 15G (Fig. 5). The absence of a
difference in the incorporation of dietary protein-derived
amino acids in myofibrillar protein may be related to the mild
attenuation in dietary-protein-derived phenylalanine availabil-
ity in the circulation when free leucine was coingested (Fig.
3B). It has been reported that the increase in muscle protein
synthesis rates following leucine administration may become
limited with inadequate provision of exogenous amino acids as
precursors (15, 16). More work will be required to determine
the optimal amount of dietary protein that should be coingested
with free leucine to ensure adequate plasma precursor avail-
ability to maximize postprandial muscle protein synthesis
rates.
The muscle protein synthetic response to protein ingestion
has been shown to be impaired in older (47) and/or more
clinically compromised populations (31, 50). Resistance-type
exercise is an effective strategy to improve the sensitivity of
skeletal muscle to the anabolic properties of dietary protein.
However, recent work from our group has demonstrated that
ingestion of less than 30 g of protein does not further increase
the muscle protein synthetic response during postexercise re-
covery in older men (22). We (34) and others (53, 54) have
shown that increasing protein intake can compensate for this
anabolic resistance, with as much as 45 g of protein being
required to achieve a robust anabolic response during exercise
recovery in older individuals. However, ingesting such large
protein amounts may not be feasible in older and/or more
clinically compromised populations. The current data extend
upon previous findings and show that free leucine coingestion
can further augment the postexercise muscle protein synthetic
response to protein ingestion (2, 7, 9, 12, 13, 30). In particular,
the total amount of leucine provided in the 15GLEU bever-
age (2.94 g) is equivalent to the amount of leucine contained in
30 g of MPC80. Therefore, increasing the leucine content
through leucine coingestion may increase the efficiency by
which the ingestion of smaller protein doses can augment
muscle protein synthesis rates during recovery from exercise.
Simply adding leucine to a postexercise snack to achieve ~3 g
total leucine, may represent an effective strategy to support
muscle mass maintenance in the older population without the
need to ingest large(r) doses of protein. So far only few
long-term intervention studies have assessed the anabolic ef-
fect of prolonged leucine supplementation. Whereas prolonged
leucine supplementation does not seem to increase muscle
mass in older individuals (27, 45), it has been suggested that
leucine supplementation may augment muscle mass when
combined with prolonged resistance-type exercise training
(43). Nonetheless, more work is needed to assess the long-term
benefits of leucine supplementation in combination with pro-
longed resistance-type exercise training in the older popula-
tion.
In conclusion, leucine coingestion further augments the
postexercise muscle protein synthetic response to the ingestion
of a small amount of protein in older men.
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